 Moderna will get $176 million in federal funding from the Department of Health and Human Services to develop a human vaccine against highly pathogenic avian influenza. The grant follows outbreaks of the virus in dairy cattle throughout several states. The U.S. has documented three cases of humans with bird flu so far this year and all had regular contact with dairy cattle. As of this month, over 130 herds in 12 states have been infected by the H5N1 virus.